세계의 항균제 시장 : 약제 클래스별, 활성 스펙트럼별, 투여 경로별, 용도별, 유통 채널별, 지역별

Global Antibacterial Drugs Market is estimated to be valued at USD 46.91 Bn in 2025 and is expected to reach USD 64.74 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.7% from 2025 to 2032.

Figure. Antibacterial Drugs Market Share (%), By Region 2025

Antibacterial drugs, also known as antibiotics, are medicines that fight bacterial infections and work by either killing or inhibiting the growth of bacteria. They are widely used for the treatment of various infections such as pneumonia, tuberculosis, anthrax, syphilis, leprosy, and listeriosis. Factors such as growth in the prevalence of infectious diseases, increasing investment by pharmaceutical companies in antibiotic research, and strong pipeline of newly developed drugs are expected to drive the market growth during the forecast period. However, stringent government regulations for the approval of new antibiotics and antibiotic resistance development may restrain the market growth to a certain extent.

Market Dynamics:

Key factors, such as increasing prevalence of bacterial infections, new product launches, and strong pipeline drugs, are projected to drive the global antibacterial drugs market during the forecast period. As per Centers for Disease Control and Prevention (CDC), in 2020 alone over 2.8 million antibiotic-resistant infections occurred in the U.S. and more than 35,000 people died. This creates significant demand for effective antibacterial drugs. Furthermore, large players are continuously focusing on R&D to develop innovative drugs. For instance, in August 2022, Pfizer Inc. received USFDA approval for its new antibiotic treatment, relebactam, to treat complicated urinary tract and intra-abdominal infections. However, factors like stringent regulations for approval of new antibiotics and increasing antibiotic resistance development are anticipated to restrain the market growth. Moreover, focus on the development of alternative treatment methods like bacteriophage therapy is expected to present lucrative opportunities in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global antibacterial drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2025 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global antibacterial drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Abbott, Merck, GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb Company, Johnson & Johnson, Sanofi, Bayer, and Novartis

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global antibacterial drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibacterial drugs market

Market Segmentation

• By Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
  • Penicillins
  • Cephalosporins
  • Aminoglycosides
  • Tetracyclines
  • Macrolides
  • Fluoroquinolones
  • Sulfonamides
  • Others
• By Spectrum of Activity Insights (Revenue, USD Bn, 2020 - 2032)
  • Broad-spectrum Antibiotics
  • Narrow-spectrum Antibiotics
• By Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
  • Oral
  • Topical
  • Intravenous
  • Other Routes
• By Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Skin Infections
  • Respiratory Infections
  • Urinary Tract Infections
  • Septicemia
  • Ear Infections
  • Gastrointestinal Infections
  • Other Applications
• By Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Novartis International AG
  • GlaxoSmithKline plc
  • Sanofi
  • Hoffmann-La Roche Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Astellas Pharma Inc.
  • Johnson & Johnson
  • Amgen Inc.
  • Bayer AG
  • Eli Lilly and Company
  • AstraZeneca plc

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Antibacterial Drugs Market, By Drug Class
  • Global Antibacterial Drugs Market, By Spectrum of Activity
  • Global Antibacterial Drugs Market, By Route of Administration
  • Global Antibacterial Drugs Market, By Application
  • Global Antibacterial Drugs Market, By Distribution Channel
  • Global Antibacterial Drugs Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Antibacterial Drugs Market, By Drug Class, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Penicillins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cephalosporins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Aminoglycosides
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tetracyclines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Macrolides
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Fluoroquinolones
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sulfonamides
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Antibacterial Drugs Market, By Spectrum of Activity, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Broad-spectrum Antibiotics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Narrow-spectrum Antibiotics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Antibacterial Drugs Market, By Route of Administration 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intravenous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Other Routes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Antibacterial Drugs Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Skin Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Respiratory Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Urinary Tract Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Septicemia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ear Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gastrointestinal Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Antibacterial Drugs Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Antibacterial Drugs Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Spectrum of Activity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Spectrum of Activity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Spectrum of Activity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Spectrum of Activity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa

10. Competitive Landscape

• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co., Inc.
• Abbott Laboratories
• Novartis International AG
• GlaxoSmithKline plc
• Sanofi
• Hoffmann-La Roche Ltd.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Astellas Pharma Inc.
• Johnson & Johnson
• Amgen Inc.
• Bayer AG
• Eli Lilly and Company
• AstraZeneca plc

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us